CTI BioPharma
Why Robinhood?
You can watch CTI BioPharma and buy or sell other stocks, ETFs, and their options commission-free!About CTIC
CTI BioPharma Corp. engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis.
CTIC Key Statistics
Stock Snapshot
With a market cap of 1.2B, CTI BioPharma(CTIC) trades at $9.09. The stock has a price-to-earnings ratio of -15.78.
During the trading day, CTI BioPharma(CTIC) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 4.57M.
The stock's 52-week range extends from a low of $4.01 to a high of $9.10.
The stock's 52-week range extends from a low of $4.01 to a high of $9.10.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.